The second annual release of Reunion — A Beer for Hope will take place during the week of February 17, 2008. This year’s beer celebrates the life of Virginia MacLean, the inspiration and one of the founding partners of the Reunion beer collaboration. (See links page at Reunion Beer for stories on the 2007 release.)
If you missed this story last year, here’s how it started.
Once upon a time, Pete Slosberg created Pete’s Wicked Ale. And the brown ale was good. He had help spreading the word, of course, and in the early days Alan Shapiro and Virginia MacLean also helped Pete’s become a nationally known microbrewery. Pete, of course, moved on to chocolate and Alan Shapiro worked for a time with Merchant Du Vin and now heads his own import company, SBS Imports. Virginia MacLean, in the meantime, left the beer business but as she approached her fortieth birthday was diagnosed with Multiple Myeloma, which is a type of bone cancer that currently has no known cure. For more information about the disease, see the MMRF or the Institute for Myeloma & Bone Cancer Research.
Last February, Pete Slosberg and Alan Shapiro got together and decided to help their friend by creating a new beer to help raise awareness and money to fund research into this disease. The beer was named “Reunion,” and it was a big, imperial brown ale and was the first commercial beer Slosberg had done since selling Pete’s Wicked Ale to Gambrinus in 1998. He worked with award-winning brewer Daniel Del Grande at Bison Brewing in creating the organic beer.
Unfortunately, last June Virginia McLean passed away in her home in Mountain View, California. But Pete and Alan decided to continue the fight against the disease that took their friend in her name and in her honor. When you start seeing this beer again this February, please buy a bottle or two to support this worthy cause.
About Multiple Myeloma & IMBCR:
Multiple Myeloma is a unique cancer of plasma cells that attacks and destroys bone. The term is derived from the multiple areas of bone marrow that are usually affected by the disease. Worldwide, over 1,000 people a day are diagnosed with this currently incurable form of bone cancer. Led by Dr. James Berenson, IMBCR is one of the world’s leading research organizations combating this disease. IMBCR specializes in developing novel chemotherapy drugs and treatments. For further information on multiple myeloma or IMBCR, please visit www.imbcr.org or contact 310-623-1210.